Profound Medical
PROF
46 hedge funds and large institutions have $128M invested in Profound Medical in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 10 closing their positions.
62% more call options, than puts
Call options by funds: $2.99M | Put options by funds: $1.85M
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.09% less ownership
Funds ownership: 42.87% → 42.78% (-0.09%)
4% less funds holding
Funds holding: 48 → 46 (-2)
11% less capital invested
Capital invested by funds: $143M → $128M (-$15M)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$3.66M |
| 2 |
GS
Gagnon Securities
New York
|
+$2.52M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$1.9M |
| 4 |
GA
Gagnon Advisors
New York
|
+$1.9M |
| 5 |
RA
Royce & Associates
New York
|
+$625K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$10.5M |
| 2 |
SM
SG3 Management
Dorado,
Puerto Rico
|
-$614K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$596K |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$534K |
| 5 |
PIC
PCJ Investment Counsel
Toronto,
Ontario, Canada
|
-$407K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Renaissance Technologies
New York
| – | -$260K | -15,900 | Closed |
|
|
AIP
52
ARS Investment Partners
New York
| – | -$164K | -10,000 | Closed |
|
|
NEI
53
Northwest & Ethical Investments
Toronto,
Ontario, Canada
| – | -$36.5K | -2,244 | Closed |
|
|
LSA
54
Leonteq Securities AG
Zurich,
Switzerland
| – | -$30.3K | -1,500 | Closed |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| – | -$9K | -530 | Closed |
|
|
ASN
56
Advisory Services Network
Atlanta,
Georgia
| – | -$2K | -100 | Closed |
|
PROF Hedge Fund Activity: Q3 2021 in Review
46 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2021, worth a combined $128M — down 11% from $143M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of PROF and 8 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 15 added.
The largest buyer was Blackcrane Capital, adding an estimated $3.66M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $10.5M sold.
- 46 institutional investors held Profound Medical (PROF) as of Q3 2021, down from 48 in Q2 2021.
- Funds reported $128M of Profound Medical stock for Q3 2021, down 11% quarter-over-quarter.
- 8 funds opened new Profound Medical positions in Q3 2021 and 10 closed out, a net change of -2 holders.
- The largest Profound Medical buyer in Q3 2021 was Blackcrane Capital, an estimated $3.66M added.
- The largest Profound Medical seller in Q3 2021 was Pura Vida Investments, an estimated $10.5M sold.
Based on aggregated 13F filings for Q3 2021.